191 related articles for article (PubMed ID: 20727186)
21. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
[TBL] [Abstract][Full Text] [Related]
22. [Establishment of in vivo adriamycin-induced multidrug resistance models of subcutaneous and hepatic transplanted human liver cancer in nude mice].
Zhai BJ; Wu F; Shao ZY; Hu K; Zhao CL; Wang ZB
Ai Zheng; 2004 Aug; 23(8):905-9. PubMed ID: 15301712
[TBL] [Abstract][Full Text] [Related]
23. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.
Lu F; Hou YQ; Song Y; Yuan ZJ
Anat Rec (Hoboken); 2013 Jan; 296(1):56-63. PubMed ID: 23125179
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.
Ding Y; Li S; Ge W; Liu Z; Zhang X; Wang M; Chen T; Chen Y; Zhang Q
Eur J Med Chem; 2019 Dec; 183():111706. PubMed ID: 31553932
[TBL] [Abstract][Full Text] [Related]
25. Biological features, gene expression profile, and mechanisms of drug resistance of two- and three-dimensional hepatocellular carcinoma cell cultures.
Mei N; Zhao N; Tian T; Jiao M; Li C
Pharmacol Res Perspect; 2021 Feb; 9(1):e00715. PubMed ID: 33486902
[TBL] [Abstract][Full Text] [Related]
26. The noncytotoxic dose of sorafenib sensitizes Bel-7402/5-FU cells to 5-FU by down-regulating 5-FU-induced Nrf2 expression.
Zhou S; Ye W; Duan X; Zhang M; Wang J
Dig Dis Sci; 2013 Jun; 58(6):1615-26. PubMed ID: 23314856
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells.
Wang XB; Wang SS; Zhang QF; Liu M; Li HL; Liu Y; Wang JN; Zheng F; Guo LY; Xiang JZ
Oncol Rep; 2010 Jan; 23(1):211-5. PubMed ID: 19956884
[TBL] [Abstract][Full Text] [Related]
28. Anticancer activity of methoxymorpholinyl doxorubicin (PNU 152243) on human hepatocellular carcinoma.
Yuan S; Zhang X; Lu L; Xu C; Yang W; Ding J
Anticancer Drugs; 2004 Jul; 15(6):641-6. PubMed ID: 15205610
[TBL] [Abstract][Full Text] [Related]
29. Suppression of BCRP expression and restoration of sensitivity to chemotherapy in multidrug-resistant HCC cell line HEPG2/ADM by RNA interference.
Li H; Zhou S; Li T; Liu Z; Wu J; Zeng G; Liu C; Gong J
Hepatogastroenterology; 2012 Oct; 59(119):2238-42. PubMed ID: 23435138
[TBL] [Abstract][Full Text] [Related]
30. Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
Naito S; Hasegawa S; Yokomizo A; Koga H; Kotoh S; Kuwano M; Kumazawa J
Jpn J Cancer Res; 1995 Nov; 86(11):1112-8. PubMed ID: 8567404
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of miR-33a-5p in Hepatocellular Carcinoma: A Possible Mechanism for Chemotherapy Resistance.
Meng W; Tai Y; Zhao H; Fu B; Zhang T; Liu W; Li H; Yang Y; Zhang Q; Feng Y; Chen G
Med Sci Monit; 2017 Mar; 23():1295-1304. PubMed ID: 28291769
[TBL] [Abstract][Full Text] [Related]
32. Synergistic effect of bromocriptine and tumor necrosis factor-alpha on reversing hepatocellular carcinoma multidrug resistance in nude mouse MDR1 model of liver neoplasm.
Ding L; Chen XP; Zhang ZW; Guan J; Zhang WG; Wang HP; Wang ZH; Li CL
World J Gastroenterol; 2005 Sep; 11(36):5621-6. PubMed ID: 16237754
[TBL] [Abstract][Full Text] [Related]
33. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line.
Wen J; Zheng B; Hu Y; Zhang X; Yang H; Luo KJ; Zhang X; Li YF; Fu JH
Oncol Rep; 2009 Jul; 22(1):65-71. PubMed ID: 19513506
[TBL] [Abstract][Full Text] [Related]
34. Human multi-drug resistant hepatocellular carcinoma induced in nude mice by B-ultrasonographically-directed orthotopic implantation: a new experimental model.
Ding L; Chen XP; Zhang ZW; Jing K; Zhang WG
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):393-8. PubMed ID: 17690036
[TBL] [Abstract][Full Text] [Related]
35. Association between reversal of multidrug resistance by methyl jasmonate and P-glycoprotein ATPase activity in hepatocellular carcinoma.
Wang CF; Wang YQ; Huang FZ; Nie WP; Liu XY; Jiang XZ
J Int Med Res; 2013 Aug; 41(4):964-74. PubMed ID: 23867448
[TBL] [Abstract][Full Text] [Related]
36. Quantitative proteomic and phosphoproteomic studies reveal novel 5-fluorouracil resistant targets in hepatocellular carcinoma.
Liu Z; Wang Y; Yao Y; Fang Z; Miao QR; Ye M
J Proteomics; 2019 Sep; 208():103501. PubMed ID: 31454556
[TBL] [Abstract][Full Text] [Related]
37. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
Gu W; Liu L; Fang FF; Huang F; Cheng BB; Li B
Oncol Rep; 2014 Jan; 31(1):216-22. PubMed ID: 24173654
[TBL] [Abstract][Full Text] [Related]
38. [Reversal of multidrug resistance of human hepatocellular carcinoma cells by wild-type p53 gene and related mechanisms].
Gai XD; Li GL; Huang JZ; Xue HJ; Wang D
Ai Zheng; 2006 Aug; 25(8):954-9. PubMed ID: 16965674
[TBL] [Abstract][Full Text] [Related]
39. Correlation between adenosine triphosphate (ATP)-binding cassette transporter G2 (ABCG2) and drug resistance of esophageal cancer and reversal of drug resistance by artesunate.
Wang L; Liu L; Chen Y; Du Y; Wang J; Liu J
Pathol Res Pract; 2018 Sep; 214(9):1467-1473. PubMed ID: 30104076
[TBL] [Abstract][Full Text] [Related]
40. The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer.
Geng M; Wang L; Chen X; Cao R; Li P
Diagn Pathol; 2013 Dec; 8():198. PubMed ID: 24326092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
